anitocabtagene autoleucel
anitocabtagene autoleucel: 1 clinical trial tracked.
anitocabtagene autoleucel evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anitocabtagene autoleucel, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma
Primary endpoint: Progression-Free Survival (PFS)
InterventionalRandomizedopen452 enrolledStarted 2024-08Completion 2031-0750 sites · Australia, United StatesKite, A Gilead Company